MKI67 and lymphoma: In conclusion, Ki67 is a valuable flow marker that can distinguish between indolent and aggressive lymphomas and identify whether indolent lymphomas are transformed, and using MFC to evaluate the positive rate of Ki67 is important in clinical settings.